Dopamine Synthesis Capacity Before Onset of Psychosis: A Prospective [ 18 F]-DOPA PET Imaging Study
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: While there is robust evidence of elevated dopamine synthesis capacity once a psychotic disorder has developed, little is known about whether it is altered prior to the first episode of frank illness. The authors addressed this issue by measuring dopamine synthesis capacity in individuals at ultra-high risk of psychosis and then following them to determine their clinical outcome. METHOD: This prospective study included 30 patients who met standard criteria for being at ultra-high risk of psychosis and 29 healthy volunteers. Participants were scanned using [(18)F]6-fluoro-L-dopa positron emission tomography. The ultra-high-risk patients were scanned at presentation and followed up for at least 3 years to determine their clinical outcome. Six patients had comorbid schizotypal personality disorder and were excluded from the analysis (data are provided for comparison). Of the remaining patients, nine developed a psychotic disorder (psychotic transition group) and 15 did not (nontransition group). RESULTS: There was a significant effect of group on striatal dopamine synthesis capacity. The psychotic transition group had greater dopamine synthesis capacity in the striatum (effect size=1.18) and its associative subdivision (effect size=1.24) than did the healthy comparison subjects and showed a positive correlation between dopamine synthesis capacity and symptom severity. Dopamine synthesis capacity was also significantly greater in the psychotic transition group than in the nontransition group. CONCLUSIONS: These findings provide evidence that the onset of frank psychosis is preceded by presynaptic dopaminergic dysfunction. Further research is needed to determine the specificity of elevated dopamine synthesis capacity to particular psychotic disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Dopamine synthesis capacity is greater in individuals who later transition to psychosis than those who do not transition (63),”
From Aberrant Salience, Information Processing, and Dopaminergic Signaling in People at Clinical High Risk for Psychosis (2020) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data
Patlak, C. S., Blasberg, R. G., & Fenstermacher, J. D. (1983) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1983.1 · Cited by 3,567
The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
Howes, O. D., & Kapur, S. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp006 · Cited by 2,693
Self-citationMapping the Onset of Psychosis: The Comprehensive Assessment of At-Risk Mental States
Yung, A. R., Yung, A. R., Pan Yuen, H., Mcgorry, P. D., Phillips, L. J., Kelly, D., Dell'olio, M., Francey, S. M., Cosgrave, E. M., Killackey, E., et al. (2005) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2005.01714.x · Cited by 2,196
Dopamine in schizophrenia: a review and reconceptualization
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.11.1474 · Cited by 2,018
The primate basal ganglia: Parallel and integrative networks
Haber, S. N. (2003) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2003.10.003 · Cited by 1,479
Hammers, A., Allom, R., Koepp, M. J., Free, S. L., Myers, R., Lemieux, L., Mitchell, T. N., Brooks, D. J., & Duncan, J. S. (2003) · Human Brain Mapping · doi:10.1002/hbm.10123 · Cited by 1,286
Cannon, T. D., Cadenhead, K., Cornblatt, B., Woods, S. W., Addington, J., Walker, E., Seidman, L. J., Perkins, D., Tsuang, M., McGlashan, T., et al. (2008) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2007.3 · Cited by 1,269
Lisman, J. E., Coyle, J. T., Green, R. W., Javitt, D. C., Benes, F. M., Heckers, S., & Grace, A. A. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.02.005 · Cited by 1,010
Elevated Striatal Dopamine Function Linked to Prodromal Signs of Schizophrenia
Howes, O. D., Montgomery, A. J., Asselin, M.-C., Murray, R. M., Valli, I., Tabraham, P., Bramon-Bosch, E., Valmaggia, L., Johns, L., Broome, M., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2008.514 · Cited by 744
Self-citation
Research works printed but not linked: 1
- American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994 American Psychiatric Association Press Washington DC Fourth edition
Cited by
Items 301–344 of 344
Epigenetics, Stress, and Their Potential Impact on Brain Network Function
Diwadkar, V. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800951-2.00015-7 · Cited by 2
Explanatory Coherence, Partial Truth and Diagnostic Validity in Psychiatry
Oulis, P. (2013) · Springer eBooks · doi:10.1007/978-3-319-01306-0_35 · Cited by 1
Salgado, J. V., Cruz, B. F., Mantovani, L. M., & Massuda, R. (2023) · Springer eBooks · doi:10.1007/978-3-031-43356-6_13 · Cited by 1
Lee, T. Y., Kim, N. S., & Im, A. (2024) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2024.104006 · Cited by 1
Bhattacharyya, S., Davies, C., Carter, B., McGuire, P. K., Brammer, M. J., Fusar‐Poli, P., Broome, M. R., Watson, S., Pérez, J. M., & Yung, A. R. (2025) · Efficacy and Mechanism Evaluation · doi:10.3310/ynfh9826 · Cited by 2
Self-citationDopamine and the Biology and Course of Treatment Resistance
Demjaha, A., & Howes, O. D. (2014) · Springer eBooks · doi:10.1007/978-3-642-45257-4_3 · Cited by 1
Self-citationVignapiano, A., DeLisi, L. E., & Galderisi, S. (2019) · Springer eBooks · doi:10.1007/978-3-319-97307-4_9 · Cited by 1
Gupta, T., Damme, K. S. F., Osborne, K. J., Vargas, T., Ristanovic, I., Frosch, I. R., Zarubin, V. C., Hitczenko, K., Williams, T. F., Cowan, H. R., et al. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818697-8.00089-3 · Cited by 1
Subcortical Origin of Salience Processing Deficits in Schizophrenia
Palaniyappan, L. K. (2022) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2021.12.008 · Cited by 1
Červenka, S., & Farde, L. (2020) · Springer eBooks · doi:10.1007/978-3-030-35206-6_8 · Cited by 1
Smazal, A. L. (2013) · Iowa State University Digital Repository (Iowa State University) · doi:10.31274/etd-180810-3278 · Cited by 1
Magnetic Resonance and Molecular Imaging in Psychiatry
Howes, O. D. (2015) · Elsevier eBooks · doi:10.1016/b978-0-08-097086-8.27040-2 · Cited by 1
Self-citationStudying biomarkers in populations at genetic and clinical high risk for psychosis
de Koning, M. B. (2013) · Research Publications (Maastricht University) · doi:10.26481/dis.20131129mk · Cited by 1
Brain Development and Schizophrenia
Freedman, R. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12081017 · Cited by 1
Sabaroedin, K., Razi, A., Chopra, S., Tran, N., Pozaruk, A., Chen, Z.-L., Finlay, A., Nelson, B., Allott, K., Alvarez-Jimenez, M., et al. (2021) · medRxiv · doi:10.1101/2021.03.11.21253426 · Cited by 2
Sportelli, L., Eisenberg, D. P., Passiatore, R., D’Ambrosio, E., Antonucci, L. A., Chen, Q., Czarapata, J., Goldman, A. L., Gregory, M. A., Griffiths, K., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.20.558594 · Cited by 1
Self-citationGiacomel, A., Martins, D., Nordio, G., Easmin, R., Howes, O. D., Selvaggi, P., Williams, S., Turkheimer, F., de Groot, M., Dipasquale, O., et al. (2023) · medRxiv · doi:10.1101/2023.11.27.23299051 · Cited by 1
Self-citationMultilevel Approaches to Schizophrenia and Other Psychotic Disorders: The Biobehavioral Interface
Walker, E. F., Ryan, A. T., Goines, K., Novacek, D. M., Goulding, S. M., Brasfield, J. L., MacDonald, A. N., & Trotman, H. D. (2016) · Wiley eBooks · doi:10.1002/9781119125556.devpsy322 · Cited by 1
Howes, O. D., Gee, S., & Taylor, D. M. (2013) · The British Journal of Psychiatry · doi:10.1192/bjp.202.3.238a
Self-citationThe significance of dopamine and glutamate for neuronal reward processing over the lifespan
Gleich, T. (2016) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-15734
Hohe Dopaminsynthese deutet auf drohenden Ausbruch einer Psychose hin
Volz, H.-P. (2012) · DNP - Der Neurologe und Psychiater · doi:10.1007/s15202-012-0257-1
Godini, L., Lelli, L., Campone, B., Ciampi, E., Corsi, E., Ramella‐Cravaro, V., & Ballerini, A. (2016)
Neto, A. F. R. (2016) · TDX (Tesis Doctorals en Xarxa)
Chen, K. C. (2016) · Research Portal (King's College London)
Neuroinflammation and psychosis; antipsychotic medication.
Bloomfield, P. S. (2015) · Spiral (Imperial College London) · doi:10.25560/39588
Treatment-Resistant Schizophrenia : Pathophysiology and Treatment
Kim, E. (2018) · 신경정신의학 · doi:10.4306/jknpa.2018.57.3.230
Chapitre 9. Imagerie dans les phases précoces de la schizophrénie
Krebs, M. (2015) · Dunod eBooks · doi:10.3917/dunod.krebs.2015.01.0143
PET and SPECT in Personality Disorders
Ziafat, K., Rosell, D. R., Ripoll, L. H., Siever, L. J., New, A. S., & Pérez-Rodríguez, M. M. (2020) · Springer eBooks · doi:10.1007/978-3-030-57231-0_20
Anvari, A., Loeb, F., Rapoport, J., & Driver, D. I. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-51147-6.00017-x
Imaging in Psychiatry: A Reappraisal of Preventative Potential
Valli, I., & Verdolini, N. (2022) · Springer eBooks · doi:10.1007/978-3-030-97906-5_14
Self-citationGunasekera, B., Davies, C., Blest‐Hopley, G., Wilson, R. P., Busatto, G. F., Crippa, J. A. S., Duran, F., Zuardi, A. W., Veronese, M., Raduà, J., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1990777/v1
The Role of the Immune System in Creating Depression, Post-traumatic-Stress-Disorder, and Psychosis
Littrell, J. L. (2024) · Integrated science · doi:10.1007/978-3-031-72079-6_2 · Cited by 1
Tubiolo, P. N., Williams, J. C., Gil, R. B., Cassidy, C., Haubold, N. K., Patel, Y., Abeykoon, S. K., Zheng, Z. J., Pham, D. T., Ojeil, N., et al. (2025) · medRxiv · doi:10.1101/2025.03.31.25324962 · Cited by 1
Biological aspects of drug resistance in schizophrenia
Tikhonov, D. V., & Kaleda, V. G. (2026) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202612601119
The potential of neuromelanin-sensitive MRI in psychiatric disorders
Neutelings, E., van de Giessen, E., de Haan, L., & van der Pluijm, M. (2026) · Neuroscience Applied · doi:10.1016/j.nsa.2026.106994 · Cited by 1
Marqueurs neurodéveloppementaux en psychiatrie : intérêt dans les troubles schizophréniques
Gay, O. (2016) · theses.fr (ABES) · doi:10.70675/b0e8f0f3ze67bz4340z9b3cz01b56b6184f0 · Cited by 3
Yang, X., Agartz, I., Andreassen, O. A., Bachman, P., Baeza, I., Bartholomeusz, C., Borgwardt, S., Choi, S., Colibazzi, T., Cooper, R. E., et al. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03586-4
Striatal dopamine synthesis in schizophrenia decreases from psychosis to psychotic remission
Schulz, J., Thalhammer, M., Bonhoeffer, M., Neumaier, V., Knolle, F., Sterner, E., Yan, Q., Hippen, R., Leucht, S., Priller, J., et al. (2026) · Brain · doi:10.1093/brain/awag333 · Cited by 1
Multi-path neural mechanisms of self–other reward integration impairment in schizophrenia
Huang, C., Sang, H., Zhao, X., Xie, P., & Zhou, A. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106715
Noninvasive Mapping of Striosome-Matrix Imbalance in Early Psychosis
Weerasekera, A., Waugh, J. L., Öngür, D., Nolan, G. P., Mody, M., & Du, F. (2026) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2026.100785
Lee, T. Y., Eom, K., Kim, J. J., Lee, Y., & Hyun, J. H. (2026) · Biological Psychiatry · doi:10.1016/j.biopsych.2026.06.029 · Cited by 1
Sato, S., Kato, T., & Toyoizumi, T. (2026) · Schizophrenia Bulletin · doi:10.1093/schbul/sbag095
Transdiagnostic Mechanisms Underlying Nonaffective Psychosis: A Role for Hippocampal Networks?
Kaplan, C., Perepezko, K., Pontone, G. M., & Bakker, A. (2026) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2026.10.010
Can neuroimaging unlock precision therapeutics in psychosis spectrum disorders?
Anticevic, A., & Yang, K. (2026) · Schizophrenia · doi:10.1038/s41537-026-00826-y · Cited by 1
Metadata
- Authors
- Howes, O. D., Bose, S. K., Turkheimer, F., Valli, I., Egerton, A., Valmaggia, L. R., Murray, R. M., & McGuire, P.
- Affiliations
- King's College London (GB)
- ORCID
- Venue
- American Journal of Psychiatry
- Published
- 2011-12
- Volume
- 168
- Issue
- 12
- Pages
- 1311-1317
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- PMC
- PMC3682447
- OpenAlex
- W2143870537
- Cited by
- 343
- References
- 40
- Citations by year
- 2026: 11 · 2025: 13 · 2024: 16 · 2023: 17 · 2022: 24 · 2021: 17 · 2020: 29 · 2019: 30 · 2018: 20 · 2017: 22 · 2016: 37 · 2015: 21 · 2014: 27 · 2013: 31 · 2012: 26
- FWCI
- 18.93
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Research Publications (Maastricht University) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- South London and Maudsley NHS Foundation Trust
- Medical Research Council
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- dopamine synthesis capacity, clinical high risk for psychosis, first-episode psychosis, striatum, 18F-DOPA PET, symptom severity, schizophrenia, schizotypal personality disorder
- MeSH terms
- Adult, Brain, Corpus Striatum, Dopamine, Female, Humans, Male, Prospective Studies, Psychotic Disorders, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.